Redifferentiation of a RET-Fusion, Radioiodine-Refractory, Differentiated Thyroid Cancer with Selpercatinib: Flip-Flop Between [¹⁸F]FDG PET/CT and ¹³¹I Posttreatment Scanning.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine Pub Date : 2025-02-03 DOI:10.2967/jnumed.124.268539

Floriane Barbry, Benjamin Chevalier, Amandine Beron, Georges Lion, Samuel Boury, Camille Marciniak, Clio Baillet, Christine Do Cao, Arnaud Jannin

引用次数: 0

查看原文本刊更多论文

Selpercatinib治疗ret融合、放射性碘难治性分化甲状腺癌的再分化：[18F]FDG PET/CT和131I治疗后扫描之间的触发器

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

自引率

0.00%

发文量

Redifferentiation of a RET-Fusion, Radioiodine-Refractory, Differentiated Thyroid Cancer with Selpercatinib: Flip-Flop Between [18F]FDG PET/CT and 131I Posttreatment Scanning.